TaiMed Biologics Inc. 4147.TWO Stock
TaiMed Biologics Inc. Price Chart
TaiMed Biologics Inc. 4147.TWO Financial and Trading Overview
| TaiMed Biologics Inc. stock price | 90.8 TWD |
| Previous Close | 98.5 TWD |
| Open | 98.1 TWD |
| Bid | 96.6 TWD x 0 |
| Ask | 96.9 TWD x 0 |
| Day's Range | 96.4 - 101 TWD |
| 52 Week Range | 52.2 - 135 TWD |
| Volume | 2.92M TWD |
| Avg. Volume | 6.68M TWD |
| Market Cap | 24.41B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.76 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 88 TWD |
4147.TWO Valuation Measures
| Enterprise Value | 24.88B TWD |
| Trailing P/E | N/A |
| Forward P/E | 284.11765 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 8.986047 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
TaiMed Biologics Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 57.34% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 135 TWD |
| 52 Week Low | 52.2 TWD |
| 50-Day Moving Average | 110.57 TWD |
| 200-Day Moving Average | 78.29 TWD |
4147.TWO Share Statistics
| Avg. Volume (3 month) | 6.68M TWD |
| Avg. Daily Volume (10-Days) | 3.42M TWD |
| Shares Outstanding | 252.67M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 17.27% |
| % Held by Institutions | 22.12% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 2.23 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 215.71M TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.89 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 10.75 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of TaiMed Biologics Inc.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 607, Ruiguang Road |
| ZIP | 11492 |
| Phone | 886 2 2658 0058 |
| Website | https://www.taimedbiologics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases. It develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase III clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which completed Phase I clinical trials for treating HIV infections; and TMB-365/TMB-380, a neutralizing HIV-1 antibody. The company was incorporated in 2007 and is headquartered in Taipei, Taiwan.
Q&A For TaiMed Biologics Inc. Stock
What is a current 4147.TWO stock price?
TaiMed Biologics Inc. 4147.TWO stock price today per share is 90.8 TWD.
How to purchase TaiMed Biologics Inc. stock?
You can buy 4147.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TaiMed Biologics Inc.?
The stock symbol or ticker of TaiMed Biologics Inc. is 4147.TWO.
Which industry does the TaiMed Biologics Inc. company belong to?
The TaiMed Biologics Inc. industry is Biotechnology.
How many shares does TaiMed Biologics Inc. have in circulation?
The max supply of TaiMed Biologics Inc. shares is 273M.
What is TaiMed Biologics Inc. Price to Earnings Ratio (PE Ratio)?
TaiMed Biologics Inc. PE Ratio is now.
What was TaiMed Biologics Inc. earnings per share over the trailing 12 months (TTM)?
TaiMed Biologics Inc. EPS is -0.76 TWD over the trailing 12 months.
Which sector does the TaiMed Biologics Inc. company belong to?
The TaiMed Biologics Inc. sector is Healthcare.